Taken together, these findings support a role for GSTP1 in chemotherapy resistance in osteosarcoma and open up the possibility that targeting GSTP1 could be a useful therapeutic strategy especially in overcoming cisplatin resistance. This evidence concerns the gene GSTP1 and osteosarcoma.